Translational Medicine
Complimentary Webinar
Health Literacy Register now >Thursday June 15, 2023 - 9AM PDT / 12PM EDT / 5PM BST / 6PM CEST
Health literacy has two sides. For the patient, their level of health literacy defines how they can obtain, process, and understand health information and services needed to make appropriate health decisions.
However, it is the responsibility of the communicator to share information in a way that is understandable.
In this webinar we will discuss the importance of applying health literacy best practices throughout the lifecycle of clinical trials and how doing so benefits everyone involved in clinical trials including the trial participants, investigators, sponsors, and the IRB/ECs.
- What health literacy is and how it is assessed. Levels of health literacy worldwide.
- What are the risks arising from low levels of health literacy?
- How health literacy helps patients make informed health decisions.
- How can applying health literacy best practices for clear communication enhance participant understanding, trust, and satisfaction?
- Why health literacy is important in clinical trials.
- How can clear communication help improve clinical trial equity and data integrity?
Moderator:
Kasra Shakeri-Nejad, Global Head Clinical Pharmacology, Translational Medicine, Novartis Institutes for Biomedical Research
Speakers:
Catina O'Leary, President & CEO, Health Literacy Media
Jessica Valencia, Director of Innovation in Patient Engagement, Novartis Institutes for Biomedical Research NIBR, Translational Medicine, Patient Insights & Experience
John H Powers, Physician/Investigator and Professor of Clinical Medicine, George Washington University School of Medicine, Adjunct Professor at the University of Maryland School of Pharmacy
Sponsored by Novartis Institutes for BioMedical Research (NIBR)